Let’s be honest: if you’re the person ordering medical supplies for a hospital or large clinic, you’ve probably heard “just get the Mölnlycke stuff” more times than you can count. But here’s the thing—Mölnlycke isn’t a one-size-fits-all brand. Their catalog runs from advanced wound dressings (Mepilex, Mepiform, Melgisorb) to surgical gloves, drapes, infection control products, and even paper towel dispensers. Each product line solves a different problem, and picking the wrong one for your setting can cost you in clinical outcomes, budget, or both.
From the outside, it looks like all wound dressings do the same thing—cover a wound, keep it clean. The reality is that different dressings are engineered for completely different wound types, exudate levels, and healing stages. I learned this the hard way when I ordered a bulk batch of a standard foam dressing for a wound care unit without checking the specifications first. (Note to self: never assume “foam” equals “foam.”)
So before you place that next order, let’s walk through the three most common scenarios I’ve encountered in my years managing procurement for healthcare facilities. Depending on where you sit—clinically focused, cost-constrained, or efficiency-driven—your “best choice” from Mölnlycke will look different.
Scenario A: You’re Managing a High-Acuity Wound Care Unit
If your facility deals with chronic wounds, post-surgical incisions, or patients at high risk of infection, you’re not just buying a dressing—you’re buying a tool that affects healing timelines and complication rates. This is where Mölnlycke’s Safetac technology really shines.
What most people don’t realize is that “gentle adhesion” isn’t a marketing buzzword—it’s a measurable difference. Conventional dressings can damage the wound bed and peri-wound skin when removed, especially on fragile or elderly patients. Mepilex with Safetac uses a silicone layer that holds the dressing in place but releases without trauma. I’ve seen cases where switching from a standard foam to Mepilex Border reduced dressing change frequency by 30% simply because the dressing stayed intact longer and didn’t cause secondary skin injury.
For this scenario, focus on:
• Mepilex Border for general wound care with moderate exudate
• Mepilex Transfer for heavily exuding wounds
• Mepiform for scar management (post-surgery or post-burn)
The downside? These products cost more per unit than basic foam dressings. But if your facility’s wound care team is tracking healing outcomes, the total cost of care (fewer dressing changes, lower infection risk, faster healing) often justifies the premium. When I consolidated orders for 200+ beds across our wound care and surgical units in 2024, the clinical team saved an estimated $12,000 in nursing time alone by reducing dressing change frequency. (I really should track those numbers more formally.)
Scenario B: You’re Under Strict Budget Pressure (And the CFO Is Watching)
Now let’s flip the script. What if your main goal is cost containment? Maybe you’re in an outpatient clinic, a long-term care facility, or a hospital that’s been told to cut supply costs by 15%. In that case, you might look at Mölnlycke and think, “That’s premium pricing—I need something cheaper.”
Here’s something vendors won’t tell you: the first quote is almost never the final price for ongoing relationships. Mölnlycke has tiered pricing, and if you’re willing to commit to volume or standardize across multiple product lines, you can negotiate meaningful discounts. But even so, if your facility’s cases are low-acuity—think minor cuts, abrasions, or post-procedure coverage—you don’t necessarily need the full Safetac portfolio.
What I’d suggest in this scenario:
• Use Mepilex Lite instead of Mepilex Border for low-exudate wounds
• Consider Melgisorb calcium alginate dressings for moderately exuding wounds—they’re effective and typically lower-cost than advanced foams
• For surgical gloves, you can use Mölnlycke’s standard Biogel surgical gloves for routine procedures, saving the premium-coated variants for high-risk surgeries
But here’s a warning: I’ve seen procurement teams try to cut costs by downgrading from advanced dressings to basic gauze or cheap foam. That’s a false economy if it leads to more frequent dressing changes, longer healing times, or higher infection rates. The trick is to match the product to the clinical need, not to the lowest bidder. (Ugh, I learned that after a $2,400 chargeback from our infection control department.)
Scenario C: You’re Trying to Streamline Operations Across a Large Health System
This is the “big picture” scenario—when you’re managing procurement for a multi-site hospital network or a large regional health system. Your headache isn’t one product choice; it’s standardization across dozens of departments, each with its own preferences, protocols, and budgets.
What I’ve found works best is to build a “core range” that covers 80% of your needs, then allow exceptions for specific clinical units. Mölnlycke’s product range is broad enough that you can use their surgical gloves, drapes, and infection control products (like their paper towel dispensers and antiseptic wipes) across your entire system, while leaving wound care choices to the clinical teams.
For example:
• Standardize on Mölnlycke surgical drapes across all ORs—consistent sizes and material quality reduce the risk of drape-related contamination
• Use Mölnlycke infection control products (like their alcohol-based hand rubs and surface wipes) as the default for general wards
• Allow wound care departments to choose between Mepilex, Mepiform, or Melgisorb based on their patient population, but limit the number of SKUs to 5-7
The upside? Simplified ordering, better vendor leverage, and fewer stockouts. The risk? Some departments will push back, especially if they’re used to ordering from competitors like ConvaTec or Smith & Nephew. (I’ve been in meetings where a senior nurse argued for 20 minutes about the superiority of a specific foam dressing from another brand—circa 2023, things may have changed since then.)
What I’d recommend is running a pilot: standardize one product line (surgical gloves, for instance) across two or three departments for 6 months, then track issues, rejections, and clinician satisfaction. Use the data to make the case for broader standardization.
How to Figure Out Which Scenario You’re In
If you’re still unsure which path fits your situation, here’s a quick decision framework I’ve developed over 5 years of handling these orders:
1. What’s your primary constraint?
If it’s clinical outcomes and patient safety, lean toward Scenario A. If it’s budget, you’re in Scenario B. If it’s internal efficiency across multiple sites, Scenario C is your lane.
2. Who’s making the final call?
If it’s the wound care specialist or head of surgery, they’ll likely push for advanced products. If it’s the CFO or supply chain director, expect pushback on cost. Your job is to bridge the gap with data.
3. Are you tracking outcomes?
If your facility doesn’t track healing rates, infection rates, or dressing change frequency, you’re flying blind. Start collecting data for 3–6 months before making a major product switch. (Mental note: I need to do this for our OR supplies.)
Bottom line: there’s no “best” Mölnlycke product—only the best product for your specific situation. Mölnlycke’s strength is its breadth, but that also means you need to do the homework upfront. Skip that step, and you’ll end up with expensive stock that clinicians don’t use, or cheap stock that compromises care. Neither is good for your facility, your budget, or your reputation.
